Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

NCT04908397 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04908397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04908397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 29, 2021
Completion date
June 30, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carnitine nutritional deficiency, familial primary pulmonary hypertension, lung diseases, primary pulmonary hypertension, pulmonary arterial hypertension